UK to Begin Siga’s Monkeypox Drug Trials as Soon as Next Week

Clinical trials for Siga Technologies Inc.’s monkeypox treatment will start as early as next week in the UK as the outbreak continues to grow, the company’s chief scientific officer told Bloomberg Law.

The UK studies will mark the first of a dozen clinical trial sites to launch around the world under the latest outbreak, Dennis E. Hruby, Siga’s executive vice president and chief scientific officer, said in an interview Tuesday.

US studies run by the National Institutes of Health are set to follow mid-September, and Canada isn’t far behind, he added. The trials could potentially ease some access ...